| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Bypass | 38 | 2022 | 192 | 4.880 |
Why?
|
| Heart Defects, Congenital | 45 | 2022 | 747 | 3.980 |
Why?
|
| Aortic Valve | 16 | 2023 | 346 | 3.730 |
Why?
|
| Cardiac Surgical Procedures | 36 | 2022 | 493 | 3.510 |
Why?
|
| Aortic Valve Stenosis | 7 | 2023 | 215 | 3.430 |
Why?
|
| Hypoplastic Left Heart Syndrome | 17 | 2025 | 117 | 2.740 |
Why?
|
| Pulmonary Valve | 10 | 2020 | 93 | 1.880 |
Why?
|
| Fontan Procedure | 11 | 2024 | 172 | 1.740 |
Why?
|
| Calcinosis | 4 | 2021 | 230 | 1.670 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2022 | 40 | 1.580 |
Why?
|
| Aorta | 10 | 2024 | 408 | 1.360 |
Why?
|
| Pulmonary Artery | 20 | 2021 | 1030 | 1.290 |
Why?
|
| Extracorporeal Membrane Oxygenation | 11 | 2013 | 281 | 1.280 |
Why?
|
| Osteogenesis | 4 | 2018 | 175 | 1.250 |
Why?
|
| Ventricular Dysfunction, Left | 7 | 2024 | 383 | 1.230 |
Why?
|
| Heart Transplantation | 14 | 2024 | 711 | 1.220 |
Why?
|
| Norwood Procedures | 6 | 2024 | 29 | 1.220 |
Why?
|
| Heart Ventricles | 12 | 2024 | 765 | 1.170 |
Why?
|
| Hemodynamics | 18 | 2024 | 1077 | 1.110 |
Why?
|
| Heart Septal Defects, Ventricular | 6 | 2022 | 40 | 1.090 |
Why?
|
| Coronary Vessel Anomalies | 7 | 2016 | 32 | 1.090 |
Why?
|
| Coronary Vessels | 3 | 2022 | 236 | 1.000 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 3 | 2022 | 24 | 0.930 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 39 | 0.930 |
Why?
|
| Postoperative Complications | 27 | 2021 | 2456 | 0.920 |
Why?
|
| Infant, Newborn | 49 | 2024 | 5688 | 0.910 |
Why?
|
| Tetralogy of Fallot | 8 | 2021 | 78 | 0.870 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2022 | 8 | 0.850 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2016 | 263 | 0.840 |
Why?
|
| Ventricular Function, Left | 9 | 2024 | 524 | 0.830 |
Why?
|
| Infant | 55 | 2025 | 8912 | 0.810 |
Why?
|
| Atrioventricular Block | 1 | 2022 | 35 | 0.790 |
Why?
|
| Abnormalities, Multiple | 3 | 2019 | 178 | 0.750 |
Why?
|
| Humans | 151 | 2025 | 128020 | 0.740 |
Why?
|
| Heart Arrest | 4 | 2019 | 307 | 0.720 |
Why?
|
| Aorta, Thoracic | 7 | 2023 | 260 | 0.720 |
Why?
|
| Transposition of Great Vessels | 2 | 2017 | 34 | 0.700 |
Why?
|
| Hemofiltration | 3 | 2013 | 30 | 0.700 |
Why?
|
| Swine | 21 | 2022 | 742 | 0.630 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2018 | 6 | 0.620 |
Why?
|
| Sinus of Valsalva | 4 | 2016 | 10 | 0.620 |
Why?
|
| Heart Valve Prosthesis | 6 | 2021 | 111 | 0.600 |
Why?
|
| Treatment Outcome | 42 | 2025 | 10110 | 0.600 |
Why?
|
| Tissue and Organ Procurement | 4 | 2024 | 288 | 0.580 |
Why?
|
| Heart Valve Diseases | 7 | 2023 | 151 | 0.570 |
Why?
|
| Alkaline Phosphatase | 4 | 2019 | 142 | 0.540 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2015 | 19 | 0.530 |
Why?
|
| Coronary Artery Disease | 3 | 2024 | 675 | 0.520 |
Why?
|
| Intensive Care, Neonatal | 2 | 2008 | 39 | 0.510 |
Why?
|
| Male | 78 | 2025 | 62758 | 0.510 |
Why?
|
| Predictive Value of Tests | 5 | 2024 | 1934 | 0.500 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 337 | 0.490 |
Why?
|
| Aortic Diseases | 3 | 2022 | 114 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.480 |
Why?
|
| Retrospective Studies | 37 | 2024 | 14404 | 0.480 |
Why?
|
| Female | 78 | 2025 | 68017 | 0.470 |
Why?
|
| Sirolimus | 1 | 2016 | 189 | 0.470 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 167 | 0.470 |
Why?
|
| Autophagy | 1 | 2017 | 265 | 0.470 |
Why?
|
| Tissue Donors | 3 | 2024 | 388 | 0.460 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 190 | 0.460 |
Why?
|
| Vascular Stiffness | 4 | 2020 | 463 | 0.460 |
Why?
|
| Child | 39 | 2025 | 20636 | 0.450 |
Why?
|
| Placental Circulation | 1 | 2014 | 63 | 0.450 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2019 | 174 | 0.450 |
Why?
|
| Animals, Newborn | 10 | 2009 | 801 | 0.440 |
Why?
|
| Heart-Assist Devices | 2 | 2016 | 536 | 0.430 |
Why?
|
| Internship and Residency | 2 | 2021 | 1043 | 0.420 |
Why?
|
| Cells, Cultured | 5 | 2023 | 4006 | 0.420 |
Why?
|
| Factor VIII | 1 | 2013 | 57 | 0.420 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 1482 | 0.410 |
Why?
|
| Cesarean Section | 1 | 2014 | 182 | 0.410 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2508 | 0.410 |
Why?
|
| Pandemics | 2 | 2022 | 1473 | 0.410 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2006 | 84 | 0.410 |
Why?
|
| Platelet Transfusion | 1 | 2013 | 59 | 0.400 |
Why?
|
| Time Factors | 22 | 2024 | 6479 | 0.400 |
Why?
|
| Acute Kidney Injury | 4 | 2022 | 777 | 0.400 |
Why?
|
| Vascular Surgical Procedures | 3 | 2019 | 294 | 0.400 |
Why?
|
| Fibrinogen | 1 | 2013 | 158 | 0.400 |
Why?
|
| Computed Tomography Angiography | 2 | 2023 | 115 | 0.390 |
Why?
|
| Hemolysis | 4 | 2016 | 199 | 0.380 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 228 | 0.380 |
Why?
|
| Echocardiography | 7 | 2023 | 623 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 3371 | 0.370 |
Why?
|
| Patient Care Team | 2 | 2008 | 597 | 0.360 |
Why?
|
| Proteomics | 2 | 2009 | 1008 | 0.360 |
Why?
|
| Coronary Circulation | 4 | 2022 | 137 | 0.340 |
Why?
|
| Hypertrophy, Right Ventricular | 2 | 2020 | 133 | 0.340 |
Why?
|
| Heart Arrest, Induced | 6 | 2016 | 31 | 0.340 |
Why?
|
| Arterio-Arterial Fistula | 2 | 2013 | 4 | 0.330 |
Why?
|
| Child, Preschool | 29 | 2025 | 10378 | 0.330 |
Why?
|
| Databases, Factual | 8 | 2013 | 1264 | 0.320 |
Why?
|
| Anesthesia | 1 | 2011 | 129 | 0.320 |
Why?
|
| Suction | 2 | 1999 | 32 | 0.310 |
Why?
|
| Coronary Angiography | 4 | 2022 | 306 | 0.310 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2012 | 91 | 0.310 |
Why?
|
| Heart Bypass, Right | 4 | 2018 | 17 | 0.310 |
Why?
|
| Bioprosthesis | 4 | 2019 | 39 | 0.300 |
Why?
|
| Equipment Design | 7 | 2016 | 515 | 0.300 |
Why?
|
| Life Support Care | 1 | 2008 | 29 | 0.300 |
Why?
|
| Oxygenators, Membrane | 2 | 2005 | 2 | 0.300 |
Why?
|
| Oxygenators | 1 | 2008 | 4 | 0.290 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 133 | 0.290 |
Why?
|
| Ventricular Function, Right | 4 | 2024 | 274 | 0.290 |
Why?
|
| Follow-Up Studies | 21 | 2021 | 4853 | 0.290 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2007 | 11 | 0.280 |
Why?
|
| Centrifugation | 2 | 2013 | 29 | 0.270 |
Why?
|
| Forecasting | 2 | 2020 | 355 | 0.270 |
Why?
|
| Infant, Low Birth Weight | 1 | 2008 | 135 | 0.270 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2011 | 53 | 0.260 |
Why?
|
| Principal Component Analysis | 2 | 2024 | 182 | 0.260 |
Why?
|
| Signal Transduction | 4 | 2023 | 4812 | 0.260 |
Why?
|
| Hematocrit | 3 | 2016 | 93 | 0.260 |
Why?
|
| Endocarditis | 2 | 2021 | 36 | 0.260 |
Why?
|
| Risk Factors | 18 | 2024 | 9696 | 0.260 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 145 | 0.260 |
Why?
|
| Cause of Death | 2 | 2008 | 392 | 0.260 |
Why?
|
| Hyperglycemia | 1 | 2010 | 326 | 0.260 |
Why?
|
| Jugular Veins | 2 | 2019 | 39 | 0.250 |
Why?
|
| Mitral Valve | 3 | 2014 | 85 | 0.250 |
Why?
|
| Inflammation | 7 | 2022 | 2646 | 0.250 |
Why?
|
| Adolescent | 23 | 2024 | 20158 | 0.250 |
Why?
|
| Membranes, Artificial | 1 | 2005 | 69 | 0.240 |
Why?
|
| Pulmonary Atresia | 2 | 2022 | 19 | 0.240 |
Why?
|
| Waiting Lists | 2 | 2024 | 237 | 0.240 |
Why?
|
| Mitral Valve Stenosis | 2 | 2014 | 18 | 0.240 |
Why?
|
| Anastomosis, Surgical | 3 | 2021 | 149 | 0.240 |
Why?
|
| Hospital Mortality | 8 | 2013 | 844 | 0.230 |
Why?
|
| Scimitar Syndrome | 1 | 2024 | 9 | 0.230 |
Why?
|
| Defibrillators, Implantable | 1 | 2007 | 297 | 0.230 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 433 | 0.230 |
Why?
|
| Blood Coagulation Disorders | 1 | 2006 | 162 | 0.230 |
Why?
|
| Coronary Aneurysm | 1 | 2004 | 13 | 0.220 |
Why?
|
| Stents | 3 | 2024 | 504 | 0.220 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2025 | 99 | 0.220 |
Why?
|
| Thymus Gland | 2 | 2021 | 309 | 0.220 |
Why?
|
| Allografts | 1 | 2024 | 136 | 0.210 |
Why?
|
| Preoperative Care | 3 | 2018 | 335 | 0.210 |
Why?
|
| Stroke Volume | 6 | 2020 | 588 | 0.210 |
Why?
|
| Animals | 26 | 2022 | 34487 | 0.210 |
Why?
|
| Risk Assessment | 10 | 2018 | 3223 | 0.210 |
Why?
|
| Catheterization | 3 | 2013 | 171 | 0.210 |
Why?
|
| Cardiovascular Surgical Procedures | 3 | 2016 | 28 | 0.210 |
Why?
|
| Endocarditis, Bacterial | 2 | 2021 | 42 | 0.210 |
Why?
|
| Length of Stay | 9 | 2013 | 1114 | 0.210 |
Why?
|
| Random Allocation | 5 | 2009 | 342 | 0.210 |
Why?
|
| Case-Control Studies | 6 | 2021 | 3324 | 0.210 |
Why?
|
| Extracorporeal Circulation | 2 | 2000 | 13 | 0.210 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2017 | 201 | 0.200 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2016 | 198 | 0.200 |
Why?
|
| Fetal Blood | 1 | 2025 | 316 | 0.200 |
Why?
|
| Aortic Coarctation | 1 | 2023 | 82 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 7 | 2021 | 1747 | 0.200 |
Why?
|
| Palliative Care | 8 | 2019 | 714 | 0.200 |
Why?
|
| Registries | 2 | 2008 | 1873 | 0.200 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 1813 | 0.200 |
Why?
|
| Surgical Wound Infection | 3 | 2022 | 281 | 0.200 |
Why?
|
| Blood Flow Velocity | 6 | 2024 | 404 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2025 | 539 | 0.200 |
Why?
|
| Oxylipins | 1 | 2022 | 31 | 0.190 |
Why?
|
| Methylprednisolone | 2 | 2000 | 82 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 1 | 2023 | 161 | 0.190 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2024 | 76 | 0.190 |
Why?
|
| Ultrafiltration | 2 | 2016 | 27 | 0.190 |
Why?
|
| Middle Aged | 20 | 2021 | 30813 | 0.190 |
Why?
|
| Probability | 3 | 2009 | 304 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2000 | 199 | 0.190 |
Why?
|
| Intraoperative Complications | 2 | 2010 | 129 | 0.190 |
Why?
|
| Brain Injuries | 1 | 2006 | 463 | 0.190 |
Why?
|
| Marfan Syndrome | 2 | 2018 | 40 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2024 | 184 | 0.180 |
Why?
|
| Cardiac Catheterization | 4 | 2022 | 516 | 0.180 |
Why?
|
| Truncus Arteriosus | 1 | 2020 | 5 | 0.180 |
Why?
|
| Age Factors | 9 | 2024 | 3100 | 0.180 |
Why?
|
| Endothelium, Vascular | 4 | 2006 | 844 | 0.180 |
Why?
|
| Adult | 21 | 2020 | 35177 | 0.170 |
Why?
|
| Postoperative Care | 2 | 2012 | 235 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 5 | 2004 | 216 | 0.170 |
Why?
|
| Heart Rate | 5 | 2013 | 797 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2010 | 2092 | 0.170 |
Why?
|
| Reference Values | 3 | 2009 | 776 | 0.170 |
Why?
|
| Survival Rate | 7 | 2018 | 1870 | 0.160 |
Why?
|
| Echocardiography, Doppler | 2 | 2024 | 108 | 0.160 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 184 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2021 | 1169 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 108 | 0.160 |
Why?
|
| Thrombophilia | 1 | 1999 | 66 | 0.160 |
Why?
|
| Receptors, Complement | 3 | 2006 | 120 | 0.160 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Autografts | 1 | 2019 | 42 | 0.160 |
Why?
|
| Heart Function Tests | 3 | 2009 | 59 | 0.160 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 190 | 0.150 |
Why?
|
| Prospective Studies | 13 | 2019 | 7035 | 0.150 |
Why?
|
| Cattle | 4 | 2019 | 962 | 0.150 |
Why?
|
| Aprotinin | 2 | 2010 | 9 | 0.150 |
Why?
|
| Societies, Medical | 4 | 2008 | 741 | 0.150 |
Why?
|
| Lung | 7 | 2022 | 3745 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 1999 | 86 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 221 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2018 | 62 | 0.150 |
Why?
|
| Endotoxemia | 1 | 2019 | 82 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 2 | 2010 | 128 | 0.150 |
Why?
|
| Incidence | 5 | 2022 | 2614 | 0.150 |
Why?
|
| Fibrinolysis | 1 | 1999 | 133 | 0.150 |
Why?
|
| Turner Syndrome | 1 | 2018 | 51 | 0.150 |
Why?
|
| Endotoxins | 1 | 2019 | 215 | 0.150 |
Why?
|
| Cardiac Care Facilities | 1 | 2017 | 12 | 0.140 |
Why?
|
| Graft Rejection | 4 | 2021 | 557 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 268 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2014 | 270 | 0.140 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 78 | 0.140 |
Why?
|
| Fatal Outcome | 3 | 2014 | 299 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2012 | 79 | 0.140 |
Why?
|
| Cryosurgery | 1 | 2018 | 56 | 0.140 |
Why?
|
| Milrinone | 2 | 2013 | 29 | 0.140 |
Why?
|
| Comorbidity | 2 | 2020 | 1537 | 0.140 |
Why?
|
| Tachycardia | 2 | 2014 | 56 | 0.140 |
Why?
|
| Sternotomy | 2 | 2022 | 25 | 0.130 |
Why?
|
| Heart Aneurysm | 1 | 1996 | 10 | 0.130 |
Why?
|
| Oxygen | 6 | 2005 | 899 | 0.130 |
Why?
|
| Hemostasis | 3 | 2016 | 71 | 0.130 |
Why?
|
| beta Catenin | 1 | 2018 | 217 | 0.130 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 157 | 0.130 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2019 | 40 | 0.130 |
Why?
|
| Curriculum | 2 | 2021 | 909 | 0.130 |
Why?
|
| Creatinine | 1 | 2018 | 478 | 0.130 |
Why?
|
| Anesthetics | 1 | 2016 | 52 | 0.130 |
Why?
|
| Aneurysm, False | 1 | 1996 | 48 | 0.130 |
Why?
|
| Survival Analysis | 4 | 2021 | 1262 | 0.130 |
Why?
|
| Program Development | 2 | 2016 | 357 | 0.130 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 32 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 189 | 0.130 |
Why?
|
| United States | 13 | 2024 | 13785 | 0.130 |
Why?
|
| Specialty Boards | 1 | 2016 | 32 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2016 | 301 | 0.120 |
Why?
|
| Research Design | 2 | 2020 | 1034 | 0.120 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 64 | 0.120 |
Why?
|
| Cardiac Output, Low | 1 | 1995 | 66 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1999 | 467 | 0.120 |
Why?
|
| Aged | 10 | 2021 | 21892 | 0.120 |
Why?
|
| Elastin | 1 | 2015 | 77 | 0.120 |
Why?
|
| Logistic Models | 4 | 2014 | 1975 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2013 | 131 | 0.120 |
Why?
|
| Certification | 1 | 2016 | 94 | 0.120 |
Why?
|
| Specialties, Surgical | 1 | 2016 | 73 | 0.120 |
Why?
|
| Transplantation, Homologous | 6 | 2021 | 389 | 0.120 |
Why?
|
| Down Syndrome | 3 | 2010 | 469 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 511 | 0.110 |
Why?
|
| RNA | 1 | 2021 | 881 | 0.110 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2014 | 48 | 0.110 |
Why?
|
| Pulmonary Circulation | 4 | 2008 | 417 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 1921 | 0.110 |
Why?
|
| Vasodilator Agents | 4 | 2013 | 323 | 0.110 |
Why?
|
| Tricuspid Atresia | 1 | 2013 | 5 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2014 | 163 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 1995 | 131 | 0.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1995 | 127 | 0.110 |
Why?
|
| Reoperation | 5 | 2021 | 541 | 0.110 |
Why?
|
| Altitude | 1 | 2018 | 451 | 0.110 |
Why?
|
| Brain | 4 | 2019 | 2615 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2016 | 124 | 0.110 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2013 | 4 | 0.100 |
Why?
|
| Proteins | 3 | 2009 | 933 | 0.100 |
Why?
|
| Blood Coagulation Factors | 2 | 2006 | 47 | 0.100 |
Why?
|
| Patient Handoff | 1 | 2013 | 31 | 0.100 |
Why?
|
| Transplantation, Autologous | 3 | 2025 | 211 | 0.100 |
Why?
|
| Hospital Rapid Response Team | 1 | 2013 | 17 | 0.100 |
Why?
|
| Heart | 1 | 2017 | 637 | 0.100 |
Why?
|
| Biopsy | 1 | 2016 | 1077 | 0.100 |
Why?
|
| Young Adult | 5 | 2020 | 12282 | 0.100 |
Why?
|
| Hospital Costs | 3 | 1998 | 114 | 0.100 |
Why?
|
| Pericardium | 1 | 2012 | 54 | 0.100 |
Why?
|
| Ligation | 2 | 2009 | 86 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2016 | 643 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2013 | 322 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1681 | 0.100 |
Why?
|
| Coronary Sinus | 1 | 2012 | 7 | 0.100 |
Why?
|
| Vascular Resistance | 6 | 1999 | 366 | 0.100 |
Why?
|
| Myocardial Contraction | 3 | 2024 | 333 | 0.100 |
Why?
|
| Lung Diseases | 3 | 2016 | 713 | 0.100 |
Why?
|
| Perfusion Imaging | 2 | 2024 | 56 | 0.100 |
Why?
|
| Evaluation Studies as Topic | 2 | 2011 | 170 | 0.090 |
Why?
|
| Quality Improvement | 2 | 2017 | 1093 | 0.090 |
Why?
|
| Operating Rooms | 1 | 2013 | 115 | 0.090 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2012 | 69 | 0.090 |
Why?
|
| Heart Septum | 2 | 2010 | 26 | 0.090 |
Why?
|
| Arteriovenous Fistula | 1 | 2012 | 35 | 0.090 |
Why?
|
| Propensity Score | 1 | 2013 | 264 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 755 | 0.090 |
Why?
|
| Gestational Age | 1 | 2014 | 868 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 2703 | 0.090 |
Why?
|
| Biomarkers | 3 | 2017 | 3874 | 0.090 |
Why?
|
| Pulmonary Veins | 2 | 2024 | 93 | 0.090 |
Why?
|
| Cohort Studies | 6 | 2021 | 5378 | 0.090 |
Why?
|
| Confidence Intervals | 2 | 2011 | 316 | 0.090 |
Why?
|
| Hospitals, Pediatric | 2 | 2011 | 505 | 0.090 |
Why?
|
| Heart Diseases | 2 | 2008 | 345 | 0.090 |
Why?
|
| Heart Atria | 2 | 2010 | 127 | 0.090 |
Why?
|
| Organ Transplantation | 2 | 2024 | 218 | 0.090 |
Why?
|
| Purines | 2 | 2022 | 168 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2006 | 615 | 0.090 |
Why?
|
| Hypothermia, Induced | 3 | 2000 | 73 | 0.090 |
Why?
|
| Mediastinitis | 1 | 2010 | 3 | 0.090 |
Why?
|
| Colorado | 5 | 2020 | 4369 | 0.080 |
Why?
|
| Odds Ratio | 4 | 2018 | 1018 | 0.080 |
Why?
|
| Apoptosis | 1 | 2019 | 2425 | 0.080 |
Why?
|
| Blood Pressure | 6 | 2005 | 1711 | 0.080 |
Why?
|
| Hemostatics | 1 | 2010 | 47 | 0.080 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2020 | 36 | 0.080 |
Why?
|
| Body Weight | 2 | 2011 | 930 | 0.080 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2009 | 12 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2010 | 47 | 0.080 |
Why?
|
| Blood Transfusion | 2 | 2016 | 291 | 0.080 |
Why?
|
| Vocal Cord Paralysis | 1 | 2009 | 29 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2010 | 50 | 0.080 |
Why?
|
| Systole | 2 | 2020 | 190 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 419 | 0.080 |
Why?
|
| Biomechanical Phenomena | 2 | 2024 | 759 | 0.080 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2009 | 49 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 97 | 0.080 |
Why?
|
| Emergencies | 1 | 2010 | 154 | 0.080 |
Why?
|
| Prognosis | 4 | 2011 | 3766 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 275 | 0.080 |
Why?
|
| Nitric Oxide | 4 | 1999 | 881 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1007 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 1995 | 705 | 0.080 |
Why?
|
| Transducers | 1 | 2008 | 26 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 169 | 0.080 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 72 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 148 | 0.070 |
Why?
|
| Metabolome | 2 | 2021 | 319 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2013 | 734 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 314 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 3936 | 0.070 |
Why?
|
| Canada | 2 | 2010 | 344 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2024 | 235 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2007 | 390 | 0.070 |
Why?
|
| North America | 1 | 2008 | 289 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1943 | 0.070 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2012 | 37 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 518 | 0.070 |
Why?
|
| Respiratory Function Tests | 2 | 2007 | 580 | 0.070 |
Why?
|
| Pregnancy | 3 | 2014 | 6355 | 0.070 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 230 | 0.070 |
Why?
|
| Electrodes, Implanted | 1 | 2007 | 104 | 0.070 |
Why?
|
| Disease Management | 1 | 2011 | 583 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 285 | 0.070 |
Why?
|
| Aptamers, Peptide | 1 | 2006 | 3 | 0.070 |
Why?
|
| Brain Ischemia | 2 | 2000 | 305 | 0.070 |
Why?
|
| Factor VII | 1 | 2006 | 22 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 315 | 0.070 |
Why?
|
| Receptor, PAR-1 | 1 | 2006 | 21 | 0.060 |
Why?
|
| Factor VIIa | 1 | 2006 | 38 | 0.060 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2006 | 43 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2006 | 115 | 0.060 |
Why?
|
| Complement Inactivating Agents | 1 | 2006 | 45 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 56 | 0.060 |
Why?
|
| Consensus | 1 | 2008 | 607 | 0.060 |
Why?
|
| Antifibrinolytic Agents | 1 | 2006 | 47 | 0.060 |
Why?
|
| Blood Component Transfusion | 1 | 2006 | 79 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2014 | 607 | 0.060 |
Why?
|
| Isotonic Solutions | 1 | 2005 | 37 | 0.060 |
Why?
|
| Data Collection | 1 | 2008 | 645 | 0.060 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2005 | 17 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2005 | 71 | 0.060 |
Why?
|
| Equipment Contamination | 1 | 2005 | 54 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 329 | 0.060 |
Why?
|
| Communication | 1 | 2011 | 838 | 0.060 |
Why?
|
| Punctures | 2 | 2010 | 40 | 0.060 |
Why?
|
| alpha-Macroglobulins | 1 | 2005 | 24 | 0.060 |
Why?
|
| Hospitals | 1 | 2010 | 631 | 0.060 |
Why?
|
| Factor Xa Inhibitors | 1 | 2006 | 169 | 0.060 |
Why?
|
| Vena Cava, Superior | 1 | 2004 | 22 | 0.060 |
Why?
|
| Birth Weight | 1 | 2008 | 499 | 0.060 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2009 | 374 | 0.060 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2004 | 5 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2019 | 302 | 0.060 |
Why?
|
| Aspirin | 1 | 2007 | 377 | 0.060 |
Why?
|
| Complement Inactivator Proteins | 1 | 2004 | 40 | 0.050 |
Why?
|
| Materials Testing | 1 | 2005 | 344 | 0.050 |
Why?
|
| Sepsis | 1 | 2010 | 562 | 0.050 |
Why?
|
| Models, Animal | 1 | 2005 | 365 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1999 | 378 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 1047 | 0.050 |
Why?
|
| Suture Techniques | 2 | 2016 | 117 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2024 | 288 | 0.050 |
Why?
|
| Cardiotonic Agents | 2 | 2012 | 124 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2024 | 86 | 0.050 |
Why?
|
| Echocardiography, Stress | 1 | 2003 | 20 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2005 | 336 | 0.050 |
Why?
|
| DiGeorge Syndrome | 1 | 2003 | 29 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 495 | 0.050 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 97 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1286 | 0.050 |
Why?
|
| International Cooperation | 2 | 2000 | 171 | 0.050 |
Why?
|
| Europe | 2 | 2000 | 359 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2005 | 624 | 0.050 |
Why?
|
| Lung Compliance | 2 | 1999 | 45 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2010 | 1199 | 0.050 |
Why?
|
| Prevalence | 3 | 2020 | 2541 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2022 | 84 | 0.050 |
Why?
|
| Lung Transplantation | 2 | 2006 | 278 | 0.050 |
Why?
|
| Pulmonary Gas Exchange | 2 | 1999 | 118 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2004 | 556 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 264 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2021 | 457 | 0.050 |
Why?
|
| Candida parapsilosis | 1 | 2021 | 3 | 0.050 |
Why?
|
| Thoracic Surgery | 2 | 2000 | 122 | 0.050 |
Why?
|
| Filtration | 2 | 2000 | 64 | 0.050 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2001 | 10 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 1260 | 0.050 |
Why?
|
| Ventricular Dysfunction | 1 | 2001 | 15 | 0.040 |
Why?
|
| Myocardium | 2 | 2023 | 967 | 0.040 |
Why?
|
| Tryptophan | 1 | 2022 | 171 | 0.040 |
Why?
|
| Niacinamide | 1 | 2021 | 73 | 0.040 |
Why?
|
| Ebstein Anomaly | 1 | 2000 | 6 | 0.040 |
Why?
|
| Methionine | 1 | 2021 | 157 | 0.040 |
Why?
|
| Kynurenine | 1 | 2021 | 105 | 0.040 |
Why?
|
| Renal Circulation | 1 | 2000 | 57 | 0.040 |
Why?
|
| Exercise Test | 1 | 2003 | 613 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 162 | 0.040 |
Why?
|
| North Carolina | 3 | 2012 | 98 | 0.040 |
Why?
|
| Coronary Disease | 2 | 2000 | 384 | 0.040 |
Why?
|
| Spin Labels | 1 | 2000 | 46 | 0.040 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 39 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2001 | 97 | 0.040 |
Why?
|
| Blood Substitutes | 1 | 2000 | 23 | 0.040 |
Why?
|
| Plasma Substitutes | 1 | 1999 | 3 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 80 | 0.040 |
Why?
|
| Brain Death | 1 | 2020 | 46 | 0.040 |
Why?
|
| Protective Agents | 1 | 2000 | 36 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 1408 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 35 | 0.040 |
Why?
|
| Diterpenes | 1 | 1999 | 32 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 5353 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2000 | 52 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 148 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 162 | 0.040 |
Why?
|
| Thromboplastin | 1 | 1999 | 69 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2013 | 478 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2001 | 290 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2020 | 177 | 0.040 |
Why?
|
| Death | 1 | 2020 | 121 | 0.040 |
Why?
|
| Lactones | 1 | 1999 | 57 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 851 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 427 | 0.040 |
Why?
|
| Time | 1 | 2019 | 75 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2020 | 285 | 0.040 |
Why?
|
| Morbidity | 2 | 2010 | 301 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2001 | 860 | 0.040 |
Why?
|
| Leukocytes | 1 | 2000 | 303 | 0.040 |
Why?
|
| Linear Models | 2 | 2011 | 816 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 1194 | 0.040 |
Why?
|
| Antibodies | 1 | 2000 | 392 | 0.040 |
Why?
|
| Cineangiography | 1 | 1997 | 9 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1999 | 204 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 254 | 0.040 |
Why?
|
| Kidney | 2 | 2022 | 1306 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2013 | 605 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 373 | 0.040 |
Why?
|
| Cardiology Service, Hospital | 1 | 1997 | 22 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2018 | 103 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 1999 | 248 | 0.030 |
Why?
|
| Dipyridamole | 1 | 1997 | 25 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 1999 | 146 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 230 | 0.030 |
Why?
|
| Edema | 1 | 1998 | 120 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2013 | 600 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 281 | 0.030 |
Why?
|
| Brachiocephalic Trunk | 1 | 2016 | 11 | 0.030 |
Why?
|
| Metabolomics | 1 | 2021 | 599 | 0.030 |
Why?
|
| Safety | 1 | 1998 | 328 | 0.030 |
Why?
|
| Replantation | 1 | 2016 | 31 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2016 | 46 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 2509 | 0.030 |
Why?
|
| Ischemia | 1 | 1999 | 394 | 0.030 |
Why?
|
| Organ Size | 2 | 2012 | 440 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2000 | 572 | 0.030 |
Why?
|
| Isoproterenol | 1 | 1995 | 111 | 0.030 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 1995 | 9 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1998 | 567 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2021 | 831 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 1037 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 3009 | 0.030 |
Why?
|
| Adenosine | 1 | 1996 | 212 | 0.030 |
Why?
|
| Computer Systems | 1 | 2014 | 44 | 0.030 |
Why?
|
| Sternum | 1 | 1994 | 25 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 222 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 1994 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 1995 | 112 | 0.030 |
Why?
|
| Weight Gain | 1 | 1998 | 503 | 0.030 |
Why?
|
| Pyridones | 1 | 1995 | 158 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1617 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1996 | 143 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1995 | 131 | 0.030 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1896 | 0.030 |
Why?
|
| Magnetics | 1 | 2013 | 44 | 0.030 |
Why?
|
| Chronic Disease | 2 | 1998 | 1690 | 0.030 |
Why?
|
| Calcitonin | 1 | 2012 | 27 | 0.020 |
Why?
|
| Airway Extubation | 1 | 2013 | 54 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2012 | 38 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2013 | 156 | 0.020 |
Why?
|
| Health Plan Implementation | 1 | 2013 | 137 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1995 | 708 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2012 | 125 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 228 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 386 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 647 | 0.020 |
Why?
|
| Hypoxia | 1 | 1998 | 1034 | 0.020 |
Why?
|
| Heart Septal Defects | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 224 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 68 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 238 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 59 | 0.020 |
Why?
|
| Live Birth | 1 | 2010 | 56 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 396 | 0.020 |
Why?
|
| Dyspnea | 1 | 2012 | 238 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2010 | 24 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2011 | 253 | 0.020 |
Why?
|
| Disease Progression | 2 | 2011 | 2598 | 0.020 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2009 | 20 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 198 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 67 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 872 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 2009 | 186 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1492 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 163 | 0.020 |
Why?
|
| Hospitals, University | 2 | 1997 | 176 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2010 | 222 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 2000 | 669 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2009 | 258 | 0.020 |
Why?
|
| Critical Care | 1 | 2010 | 550 | 0.020 |
Why?
|
| Densitometry | 1 | 2005 | 33 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 108 | 0.010 |
Why?
|
| Metalloproteases | 1 | 2005 | 43 | 0.010 |
Why?
|
| Pediatrics | 1 | 2013 | 1044 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 2004 | 33 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 16574 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2004 | 44 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2005 | 212 | 0.010 |
Why?
|
| Angioplasty | 1 | 2004 | 47 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2004 | 48 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2005 | 258 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2004 | 90 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2004 | 131 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2005 | 298 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 332 | 0.010 |
Why?
|
| Rest | 1 | 2003 | 120 | 0.010 |
Why?
|
| Immunity | 1 | 2003 | 132 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 822 | 0.010 |
Why?
|
| Immune System | 1 | 2003 | 176 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2001 | 24 | 0.010 |
Why?
|
| Physical Endurance | 1 | 2003 | 262 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2001 | 53 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 75 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2001 | 45 | 0.010 |
Why?
|
| Quality of Life | 1 | 2012 | 2672 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2003 | 271 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 295 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 189 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 5034 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 2000 | 30 | 0.010 |
Why?
|
| Ginkgolides | 1 | 1999 | 4 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 311 | 0.010 |
Why?
|
| Ventilators, Mechanical | 1 | 2000 | 53 | 0.010 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2000 | 64 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 165 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2000 | 101 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 1096 | 0.010 |
Why?
|
| Microcirculation | 1 | 1999 | 137 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 699 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2000 | 288 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1999 | 104 | 0.010 |
Why?
|
| Perfusion | 1 | 1999 | 188 | 0.010 |
Why?
|
| Radiography | 1 | 2001 | 794 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1999 | 181 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 411 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 1984 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2000 | 853 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 200 | 0.010 |
Why?
|
| Oregon | 1 | 1996 | 69 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2000 | 630 | 0.010 |
Why?
|
| Gene Expression | 1 | 2001 | 1454 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 323 | 0.010 |
Why?
|
| Edema, Cardiac | 1 | 1994 | 3 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1996 | 661 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1182 | 0.010 |
Why?
|
| Recurrence | 1 | 1996 | 993 | 0.010 |
Why?
|
| Liver | 1 | 2001 | 1826 | 0.010 |
Why?
|
| Survivors | 1 | 1996 | 462 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 7029 | 0.000 |
Why?
|